SP
DXCM icon

SIH Partners’s DexCom DXCM Stock Holding History

SIH Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,726
Closed -$254K – 213
2025
Q1 		$254K Buy
+3,726
New +$304K 0.01% 210

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

SIH Partners's DXCM Position: Q2 2025 in Review

SIH Partners sold out of DexCom (DXCM) in Q2 2025, closing a stake of 3,726 shares — an estimated $254K sold.

SIH Partners first reported a position in DXCM in Q1 2025 and held it in 1 quarter. The position peaked at $254K in Q1 2025. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • SIH Partners reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • SIH Partners sold 3,726 DexCom shares in Q2 2025, an estimated $254K.
  • SIH Partners first reported a position in DexCom in Q1 2025 and held it in 1 quarter.
  • SIH Partners's DexCom position peaked at $254K in Q1 2025.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.